These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The role of chemotherapy in advanced thymoma. Schmitt J; Loehrer PJ J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S357-60. PubMed ID: 20859133 [TBL] [Abstract][Full Text] [Related]
5. Are Anthracycline-Based Regimens Truly Indicated To Be the Standard Chemotherapy Regimen for Thymic Carcinoma? Hirai F; Toyozawa R; Nosaki K; Seto T J Thorac Oncol; 2016 Jan; 11(1):115-21. PubMed ID: 26762746 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy. Kossai M; Duchemann B; Boutros C; Caramella C; Hollebecque A; Angevin E; Gazzah A; Bahleda R; Ileana E; Massard C; Vielh P; Soria JC; Besse B Lung Cancer; 2015 Sep; 89(3):306-10. PubMed ID: 26160757 [TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy for thymic carcinoma]. Okuma Y Gan To Kagaku Ryoho; 2012 May; 39(5):702-7. PubMed ID: 22584319 [TBL] [Abstract][Full Text] [Related]
8. Current chemotherapy options for thymic epithelial neoplasms. Papadopoulos KP; Thomas CR Expert Opin Pharmacother; 2005 Jun; 6(7):1169-77. PubMed ID: 15957970 [TBL] [Abstract][Full Text] [Related]
9. Targeted therapy for advanced thymic tumors. Rajan A; Giaccone G J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S361-4. PubMed ID: 20859134 [TBL] [Abstract][Full Text] [Related]
10. Systemic treatment of advanced thymic malignancies. Kelly RJ Am Soc Clin Oncol Educ Book; 2014; ():e367-73. PubMed ID: 24857125 [TBL] [Abstract][Full Text] [Related]
11. Response to sorafenib in cisplatin-resistant thymic carcinoma: a case report. Li XF; Chen Q; Huang WX; Ye YB Med Oncol; 2009; 26(2):157-60. PubMed ID: 18846437 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents. Caponigro F; Milano A; Basile M; Ionna F; Iaffaioli RV Curr Opin Oncol; 2006 May; 18(3):247-52. PubMed ID: 16552236 [TBL] [Abstract][Full Text] [Related]
13. [Cytotoxic Agents and Immune Checkpoint Inhibitors]. Kawazoe A; Shitara K Gan To Kagaku Ryoho; 2017 Sep; 44(9):717-721. PubMed ID: 28912395 [TBL] [Abstract][Full Text] [Related]
14. Response to cytotoxic chemotherapy in patients previously treated with palliative-intent chemotherapy for advanced thymic carcinoma. Okuma Y; Hosomi Y; Takahashi S; Maeda Y; Okamura T; Hishima T Clin Lung Cancer; 2015 May; 16(3):221-7. PubMed ID: 25468802 [TBL] [Abstract][Full Text] [Related]
15. Systemic treatments for thymoma and thymic carcinoma: A systematic review. Berghmans T; Durieux V; Holbrechts S; Jungels C; Lafitte JJ; Meert AP; Moretti L; Ocak S; Roelandts M; Girard N Lung Cancer; 2018 Dec; 126():25-31. PubMed ID: 30527189 [TBL] [Abstract][Full Text] [Related]
16. Systemic treatment for thymic malignancies. Girard N; Merveilleux du Vignaux C Curr Opin Oncol; 2017 Mar; 29(2):112-117. PubMed ID: 28027106 [TBL] [Abstract][Full Text] [Related]
17. Targeted therapies for thymic malignancies. Girard N Thorac Surg Clin; 2011 Feb; 21(1):115-23, viii. PubMed ID: 21070993 [TBL] [Abstract][Full Text] [Related]
18. Current Drug Targets for Thymic Neoplasms. Xu XL; Mao WM Curr Cancer Drug Targets; 2015; 15(7):593-603. PubMed ID: 26077729 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy and targeted agents for thymic malignancies. Girard N Expert Rev Anticancer Ther; 2012 May; 12(5):685-95. PubMed ID: 22594902 [TBL] [Abstract][Full Text] [Related]
20. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Loehrer PJ; Jiroutek M; Aisner S; Aisner J; Green M; Thomas CR; Livingston R; Johnson DH Cancer; 2001 Jun; 91(11):2010-5. PubMed ID: 11391579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]